Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ethylene diamine tetra acetic acid (EDTA) is a polyamino carboxylic acid and a hexadentate ligand widely utilized in endodontics as a chelating agent. Typically used in a 17% aqueous solution, EDTA is employed during root canal treatment to remove the inorganic component of the smear layer produced by mechanical instrumentation. By sequestering calcium ions from the hydroxyapatite of the dentin, EDTA softens the canal walls, facilitates mechanical cleaning, and opens dentinal tubules to allow better penetration of obturation sealers and medicaments. In the context of the study by Dow University of Health Sciences, EDTA serves as the gold standard comparator against other irrigants like SmearOFF and maleic acid to evaluate its effects on sealer penetration and dentin erosion.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ethylene diamine tetra acetic acid.